Skin cancer in organ transplant recipients--where do we stand today?
about
Skin cancer in organ transplant recipients: effects of immunosuppressive medications on DNA repairMelanoma Risk and Survival among Organ Transplant Recipients.Photodynamic Therapy and Non-Melanoma Skin CancerXRCC3 C18067T polymorphism contributes a decreased risk to both basal cell carcinoma and squamous cell carcinoma: evidence from a meta-analysis.Genome-wide screening for genes associated with FK506 sensitivity in fission yeastNext-generation sequencing fails to identify human virus sequences in cutaneous squamous cell carcinoma.Histopathological variants of cutaneous squamous cell carcinoma: a review.Pathogenesis of nonmelanoma skin cancers in organ transplant recipientsIncreased Tc22 and Treg/CD8 ratio contribute to aggressive growth of transplant associated squamous cell carcinoma.Risk of merkel cell carcinoma after solid organ transplantation.Cyclosporine a mediates pathogenesis of aggressive cutaneous squamous cell carcinoma by augmenting epithelial-mesenchymal transition: role of TGFβ signaling pathway.Non-melanoma skin cancer in renal transplant recipients: a study in a Brazilian reference center.Genetic variants in TLR2 and TLR4 are associated with markers of monocyte activation: the Atherosclerosis Risk in Communities MRI StudyPremalignant and Malignant Skin Lesions in Two Recipients of Vascularized Composite Tissue Allografts (Face, Hands)Graft-versus-host disease: role of inflammation in the development of chromosomal abnormalities of keratinocytesA phase III skin cancer chemoprevention study of DFMO: long-term follow-up of skin cancer events and toxicity.HIV infection status, immunodeficiency, and the incidence of non-melanoma skin cancerChronic kidney disease and cancer: a troubling connectionProgress and prospects for L2-based human papillomavirus vaccinesEfficacy of an educational intervention with kidney transplant recipients to promote skin self-examination for squamous cell carcinoma detection.Critical review of preclinical approaches to evaluate the potential of immunosuppressive drugs to influence human neoplasia.Photodynamic therapy for actinic keratosis in organ transplant patients.Real-life experience of managing vulval erosive lichen planus: a case-based review and U.K. multicentre case note audit.Actinic keratosis: a clinical and epidemiological revision.Effect of GSTM1 polymorphism on risks of basal cell carcinoma and squamous cell carcinoma: a meta-analysis.Squamous cell carcinoma with rhabdoid phenotype of skin/soft tissue in a transplant patient: an exceptional case and review of the literature.Immune cell dysfunction and inflammation in end-stage renal disease.Update on the long-term complications of renal transplantation.Melatonin's protective effect against UV radiation: a systematic review of clinical and experimental studies.Non-melanoma skin cancer is reduced after switch of immunosuppression to mTOR-inhibitors in organ transplant recipients.Genetics and nonmelanoma skin cancer in kidney transplant recipients.Post-transplantation malignancies: here today, gone tomorrow?Development of a squamous cell carcinoma mouse model for immunotoxicity testing.Basic aspects of the pathogenesis and prevention of non-melanoma skin cancer in solid organ transplant recipients: a review.Skin Cancers in Organ Transplant Recipients.Immunotoxicologic effects of cyclosporine on tumor progression in models of squamous cell carcinoma and B-cell lymphoma in C3H mice.Resveratrol-mediated downregulation of Rictor attenuates autophagic process and suppresses UV-induced skin carcinogenesis.Functional characterization of cancer-associated fibroblasts of human cutaneous squamous cell carcinoma.[Cutaneous manifestations in renal diseases].Risk of skin cancer in multiple myeloma patients: a retrospective cohort study.
P2860
Q26822549-075AD87C-1654-4D6B-8F69-BF8CBD78047DQ27320787-D4F2BAA4-EA10-4CBF-9DCC-8C55A4619E30Q28066173-791324B5-92BD-420D-843E-414AF2CC0CA6Q30358213-B3962762-1C75-4F93-893C-AEA8DE12480BQ33995703-52FFEC4B-6A33-4B9B-97A9-C6CC40FABD9EQ34226297-43EA6DCB-8EEA-4915-8943-68CC3FE2B8F8Q34479227-EB8C4CCE-2D52-41BA-A29B-4F03BBFA3825Q34713840-24C25A90-FE4F-47A7-8373-DA99C1F0B18FQ34717034-1301629C-8CF0-4C2A-89D2-22E2FC711F51Q35029320-AE77129E-45FB-407C-B9F6-3670809998B5Q35032846-94F57B47-BD81-4039-AAE4-3003E911FA74Q35850054-65224BBF-0489-45F9-B974-E96A573A6405Q36158656-CFCC356B-3F54-43A9-9979-BE43DE13E5C2Q36209013-B7D761FE-ED60-4B99-895C-2E7919289B29Q36222116-F05A3EA3-BEC7-488E-8D81-AFF801B8B096Q36457059-12A07695-B1C9-4180-8984-C7186B1DA1D5Q36659641-A6CC39B0-FDB9-4273-B823-33C37C4DA433Q36773023-A0604247-82C9-4C2B-87D9-0848CC29FD21Q37014047-3850C248-12E5-40E5-A1FE-450279EAF687Q37260801-898FFA8C-E72C-4B22-BA18-6E02BAA173BDQ37795414-C6C555FF-0A5C-49D0-B041-3901FB573C93Q37965984-ACA2C161-4D5A-4770-B137-DF32D96E259FQ37989990-C9C29651-019A-4DC1-963E-7E6569E6D51BQ38020129-D602D3A3-8334-4DB9-9B1C-A384BC918ACDQ38062894-CA7EF066-E496-4463-A40C-3960CBDA9AC6Q38075526-DD5B4B26-A2CF-4D0D-8A43-8CF6ECA91B6CQ38090908-553E6C32-A5C4-4133-87D2-E00A00D2A27CQ38104335-95CD1DA7-1C26-46B4-819C-AC7073859B37Q38155904-8EA05DE8-FC57-43BB-BCEF-B393B78EDD5CQ38210623-9723677A-0F23-424A-9FD4-C391D5A7C471Q38330222-75D05125-B567-461A-ACEF-4226D4873CB5Q38611709-C4BD9DE7-9024-4C60-B887-721EE4D9EAA8Q38871984-4270B7A2-B399-498B-AA47-879AEF7C4109Q39015006-AB0D90A6-73B6-4990-AE2A-2D41D151A50AQ39337780-1B82264A-0D0E-445D-BBEA-81B5E0046493Q39402703-4E48F993-91AB-4516-A797-8C04AFD1C0FEQ39407091-FC1E9FEC-AF80-41C7-9C1A-953661A76C97Q39535994-2C749403-C073-4E44-ADD7-FBAF600B8A64Q40460347-B1645DDA-3906-422B-B2B7-FE8B11A1C512Q40912690-93A91854-9AE2-4FC5-9621-3C8171CE5DC8
P2860
Skin cancer in organ transplant recipients--where do we stand today?
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 08 September 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Skin cancer in organ transplant recipients--where do we stand today?
@en
Skin cancer in organ transplant recipients--where do we stand today?
@nl
type
label
Skin cancer in organ transplant recipients--where do we stand today?
@en
Skin cancer in organ transplant recipients--where do we stand today?
@nl
prefLabel
Skin cancer in organ transplant recipients--where do we stand today?
@en
Skin cancer in organ transplant recipients--where do we stand today?
@nl
P2093
P1476
Skin cancer in organ transplant recipients--where do we stand today?
@en
P2093
E Stockfleth
J Kanitakis
P304
P356
10.1111/J.1600-6143.2008.02386.X
P407
P577
2008-09-08T00:00:00Z